WHO ICTRP trial
Confirmatory study of DSP-5423 in pediatric patients with schizophrenia.
JPRN-jRCT2080221682 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080221682 |
|---|---|
| Public title | Confirmatory study of DSP-5423 in pediatric patients with schizophrenia. |
| Scientific title | Confirmatory study of DSP-5423 in pediatric patients with schizophrenia. |
| Primary sponsor | Sumitomo Dainippon Pharma Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan |
| Conditions | Schizophrenia |
| Interventions | investigational material(s) Generic name etc : DSP-5423 (blonanserin) INN of investigational material : Blonanserin Therapeutic category code : 117 Psychotropic agents Dosage and Administration for Investigational material : Oral control… |
| Registration date | Dec 28, 2011 |
| Target size | 150 |
| Secondary IDs | JapicCTI-111724 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: